WallStreetZenWallStreetZen

NASDAQ: ATYR
Atyr Pharma Inc Stock Ownership - Who owns Atyr Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atyr Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jane A. GrossDirector2025-03-173,750$4.00
$15.00kBuy
Jill Marie BroadfootChief Financial Officer2025-02-041,254$3.78
$4.74kSell
Nancy DenyesGeneral Counsel2025-02-04899$3.78
$3.40kSell
Paul SchimmelDirector2024-07-2452,300$1.93
$101.04kBuy
Paul SchimmelDirector2024-07-236,648$1.82
$12.07kBuy
Paul SchimmelDirector2024-07-2241,052$1.74
$71.51kBuy
Nancy DenyesGeneral Counsel2024-06-055,000$1.86
$9.28kBuy
Sanjay ShuklaPresident and CEO2024-05-3120,000$1.81
$36.14kBuy
Jill Marie BroadfootChief Financial Officer2024-05-315,000$1.79
$8.95kBuy
Timothy CoughlinDirector2024-05-3050,000$1.75
$87.50kBuy

1 of 1

ATYR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATYR insiders and whales buy or sell their stock.

ATYR Shareholders

What type of owners hold Atyr Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Federated Hermes Inc16.51%14,666,600$49.57MInstitution
Fmr LLC13.61%12,097,429$40.89MInstitution
Point72 Asset Management LP5.50%4,883,197$16.51MInstitution
Vanguard Group Inc4.06%3,604,927$12.18MInstitution
Tikvah Management LLC2.77%2,460,833$8.32MInstitution
Srinivas Akkaraju2.10%1,866,126$6.31MInsider
Sofinnova Venture Partners IX LP2.10%1,866,126$6.31MInsider
Amir Nashat2.07%1,840,564$6.22MInsider
Polaris Venture Management Co V LLC2.06%1,827,992$6.18MInsider
Domain Partners VIII LP2.03%1,807,820$6.11MInsider

1 of 3

ATYR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATYR61.76%17.31%Net BuyingNet Buying
SEPN66.05%33.95%Net BuyingNet Buying
RNAC14.07%85.93%Net BuyingNet Buying
GLUE33.59%66.41%Net SellingNet Buying
PHAT67.34%32.66%Net SellingNet Buying
View Top Biotech Stocks

Atyr Pharma Stock Ownership FAQ

Who owns Atyr Pharma?

Atyr Pharma (NASDAQ: ATYR) is owned by 61.76% institutional shareholders, 17.31% Atyr Pharma insiders, and 20.93% retail investors. Srinivas Akkaraju is the largest individual Atyr Pharma shareholder, owning 1.87M shares representing 2.10% of the company. Srinivas Akkaraju's Atyr Pharma shares are currently valued at $6.48M.

If you're new to stock investing, here's how to buy Atyr Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.